Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, September 2003, p. 3021-3024, Vol. 47, No. 9
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.9.3021-3024.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Pascale Bonnafous,1 Stéphanie Précigout,1 David Boutolleau,1 Agnès Gautheret-Dejean,1,2 and Henri Agut1*
Laboratoire de Virologie, UPRES EA2387, CERVI, Groupe Hospitalier Pitié-Salpêtrière, 75013 Paris,1 Laboratoire de Microbiologie, Faculté des Sciences Pharmaceutiques et Biologiques, 75006 Paris, France2
Received 27 December 2002/ Returned for modification 10 April 2003/ Accepted 24 June 2003
A quantitative real-time PCR assay was developed for the determination of antiviral drug susceptibility and growth kinetics of human herpesvirus 6. The susceptibility and fitness of a sensitive strain, HST, and its ganciclovir-resistant derivative, GCVR1, were then characterized, leading us to conclude that the mutations of this latter virus did not alter its fitness significantly.
Present address: UEPSD-INRA, Domaine de Vilbert, 78352 Jouy-en-Josas Cedex, France.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |